The fourth vaccine to receive approval in parts of Europe, the Novavax shot, hasn't had any reports that I could find of myocarditis.

Disclosure : I hold no position in NVAX, short sell or options. I also don't hold Takeda Pharmaceuticals, at either their US listed shares or CFDs of their Tokyo listing.

The fourth vaccine to receive approval in parts of Europe, the Novavax shot, hasn't had any reports that I could find of myocarditis.

Disclosure : I hold no position in NVAX, short sell or options.